| Literature DB >> 28862668 |
Hui Wang1, Tong Li2, Hongjun Xiang3, Xinyu Zhang4, Kang Fang5, Gaorong Wu6, Mengmeng Yan7, Nannan Xue8, Meng Chen9, Tianxin Xie10, Yuzhong Zhang11, Penglong Wang12, Haimin Lei13.
Abstract
Previous studies have shown that compounds in the form of precipitate (CFP) from Huang-Lian-Jie-Du-Tang (HLJDT) were stable, and the CFP content reached 2.63% of the whole decoction and had good neuroprotective effects. However, there has been no research on their specific source. In this study, it was found that HLJDT CFP mainly came from the reaction of Scutellaria baicalensis and Coptis chinensis by studying the separated prescription components (accounting for 81.33% of HLJDT CFP). Unlike previous studies on HLJDT CFP, in this research the chemical composition of Scutellaria baicalensis-Coptis chinensis (SB-CC) CFP was identified by high performance liquid chromatography coupled with mass spectrometry (HPLC-MSn), which further proved that the main source of HLJDT CFP was Scutellaria baicalensis-Coptis chinensis CFP compared with previous HLJDT CFP studies. To explain the reaction mechanism between the decoctions of Scutellaria baicalensis and Coptis chinensis, isothermal titration calorimetry (ITC) was used to analyze their binding heat and the thermodynamic parameters (ΔH, ΔS, ΔG, n, Ka) of the reaction between baicalin and berberine, which are the main components of Scutellaria baicalensis and Coptis chinensis, respectively. The results showed that the reaction between decoctions of Scutellaria baicalensis and Coptis chinensis was exothermic and the reaction between baicalin and berberine was a spontaneous and enthalpy-driven chemical reaction, the binding ratio being 1:1. In addition, HLJDT CFP (EC50 = 14.71 ± 0.91 µg/mL) and SB-CC CFP (EC50 = 6.11 ± 0.12 µg/mL) showed similar protective activities on PC12 cells injured by cobalt chloride (CoCl₂). This study provided a new angle to research on the main chemical components and therapeutic values of CFP in Traditional Chinese Medicine compounds.Entities:
Keywords: Huang-Lian-Jie-Du-Tang (HLJDT); compounds in the form of precipitation (CFP); isothermal titration calorimetry (ITC); neuroprotective effect; separated prescriptions
Mesh:
Substances:
Year: 2017 PMID: 28862668 PMCID: PMC6151706 DOI: 10.3390/molecules22091456
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
The formation rate of HLJDT CFP and seven separated prescriptions from different batches.
| No. | Batch | Total Weight | Precipitate Weight | Precipitation Rate | Separated Precipitate CFP among HLJDT CFP | ||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | 9.01 g | 6.00 g | 5.98 g | 9.00 g | 29.99 g | 0.78 g | 2.60% | ||
| 2 | 8.97 g | 5.99 g | 5.99 g | 9.01 g | 29.98 g | 0.71 g | 2.37% | ||
| 3 | 8.99 g | 6.01 g | 5.98 g | 9.02 g | 30.00 g | 0.75 g | 2.50% | ||
| average | 29.99 ± 0.01 g | 0.75 ± 0.04 g | 2.49 ± 0.12% | ||||||
| 1 | 9.00 g | 6.01 g | 15.01 g | 0.62 g | 4.13% | ||||
| 2 | 8.99 g | 5.99 g | 14.98 g | 0.58 g | 3.87% | ||||
| 3 | 9.01 g | 5.98 g | 14.99 g | 0.63 g | 4.20% | ||||
| average | 14.99 ± 0.02 g | 0.61 ± 0.03 g | 4.07 ± 0.20% | 81.33% | |||||
| 1 | 5.99 g | 5.98 g | 11.97 g | 0.06 g | 0.51% | ||||
| 2 | 6.01 g | 6.00 g | 12.01 g | 0.05 g | 0.42% | ||||
| 3 | 6.03 g | 5.99 g | 12.02 g | 0.06 g | 0.50% | ||||
| average | 12.00 ± 0.03 g | 0.06 ± 0.01 g | 0.48 ± 0.06% | 8.00% | |||||
| 1 | 9.02 g | 9.03 g | 18.05 g | — a | — | ||||
| 2 | 9.00 g | 9.00 g | 18.00 g | — | — | ||||
| 3 | 9.02 g | 8.99 g | 18.01 g | — | — | ||||
| average | 18.02 ± 0.03 g | — | — | ||||||
| 1 | 6.00 g | 8.98 g | 14.98 g | — | — | ||||
| 2 | 6.01 g | 8.99 g | 15.00 g | — | — | ||||
| 3 | 5.98 g | 9.00 g | 14.98 g | — | — | ||||
| average | 14.99 ± 0.01 g | — | — | ||||||
| 1 | 6.03 g | 8.99 g | 15.02 g | — | — | ||||
| 2 | 5.98 g | 9.01 g | 14.98 g | — | — | ||||
| 3 | 6.01 g | 9.03 g | 15.04 g | — | — | ||||
| average | 15.01± 0.04 g | — | — | ||||||
| 1 | 8.98 g | 6.01 g | 14.99 g | — | — | ||||
| 2 | 9.01 g | 6.02 g | 15.03 g | — | — | ||||
| 3 | 9.00 g | 5.97 g | 14.97 g | — | — | ||||
| average | 15.00± 0.01 g | — | — |
—a represented precipitation weight <0.05 g or Precipitation Rate <0.33%.
Figure 1The experimental phenomena of SB-PC SB-CC, SB-GJ, GJ-PC, PC-CC, GJ-CC.
Figure 2The HPLC chromatogram of SB-CC CFP. The numbers 1 to 5 represent five major chemical constituents.
ESI-MSn ions of the identified compounds.
| Peak | Tr (min) | Compounds | Ms ( | Ms2 ( |
|---|---|---|---|---|
| 27.401 | Coptisine | 319.81 [M]+ | 291.87 [M − C2H4]+ | |
| 29.001 | Baicalin | 446.97 [M + H]+ | 270.75 [M + H − GLU]+ | |
| 31.008 | Palmatine | 351.92 [M]+ | 335.86 [M − CH4]+ | |
| 307.85 [M − CH4 − C2H4]+ | ||||
| 32.034 | Berberine | 335.85 [M]+ | 319.81 [M − CH4]+ | |
| 291.82 [M − CH4 − C2H4]+ | ||||
| 34.899 | Wogonoside | 460.97 [M + H]+ | 284.80 [M + H − Glu]+ |
Figure 3The reactive profiles of colliquefaction (a) Calorimetric titration of deionized water with Scutellaria baicalensis decoction; (b) Calorimetric titration of deionized water with Coptis chinensis decoction; (c) Calorimetric titration of Scutellaria baicalensis decoction with Coptis chinensis decoction.
Binding heat of all titrations.
| No. | Berberine into Baicalin (μJ) | Berberine into Water (μJ) | Baicalin into Water (μJ) | |||
|---|---|---|---|---|---|---|
| 1 | — | — | — | — | — | — |
| 2 | 594.11 | −228.2 | −122.09 | 313.21 | −22.00 | −3.35 |
| 3 | 629.88 | −189.2 | −125.01 | 358.41 | −23.77 | −4.36 |
| 4 | 720.57 | −161.6 | −123.93 | 325.81 | −24.89 | −3.85 |
| 5 | 554.46 | −139.1 | −119.18 | 323.80 | −24.49 | −3.55 |
| 6 | 483.12 | −119.7 | −115.41 | 313.13 | −22.15 | −3.50 |
| 7 | 411.30 | −104.6 | −100.42 | 219.95 | −19.87 | −3.20 |
| 8 | 315.20 | −94.20 | −99.69 | 126.31 | −18.40 | −3.13 |
| 9 | 215.62 | −86.06 | −93.10 | 61.22 | −14.93 | −2.81 |
| 10 | 147.73 | −74.72 | −87.18 | 44.42 | −12.87 | −2.58 |
| 11 | 92.88 | −69.86 | −81.03 | 27.56 | −9.98 | −2.86 |
| 12 | 55.09 | −64.10 | −76.37 | 17.60 | −8.68 | −2.60 |
| 13 | 26.51 | −57.33 | −73.13 | 0.78 | −7.15 | −2.34 |
| 14 | 6.84 | −51.45 | −66.79 | −15.98 | −4.01 | −2.14 |
| 15 | −6.99 | −45.71 | −63.61 | −4.83 | −2.49 | −2.00 |
| 16 | −18.57 | −41.89 | −62.47 | −7.92 | 0.06 | −2.01 |
| 17 | −25.25 | −36.65 | −59.78 | 5.23 | −0.80 | −2.07 |
| 18 | −29.76 | −33.33 | −56.14 | 0.85 | 0.36 | −1.75 |
| 19 | −31.58 | −30.35 | −52.34 | 3.31 | 1.80 | −1.16 |
| 20 | −33.05 | −27.86 | −50.15 | −10.56 | 2.11 | −1.70 |
‘—’ the deviation of the first drops was large, so they were eliminated.
Figure 4The reactive profiles of colliquefaction (a) Calorimetric titration of deionized water with 0.04 mmol/L baicalin solution; (b) Calorimetric titration of deionized water with 0.4 mmol/L berberine solution; (c) Clorimetric titration of 0.04 mmol/L baicalin solution with 0.4 mmol/L berberine solution and the heating curve of baicalin solution titrated by berberine solution; (d) Structure of berberine; (e) Structure of baicalin.
Binding thermodynamics of baicalin and berberine.
| No. | Δ | − | Δ | n | Ka (1/M) | Kd (M) |
|---|---|---|---|---|---|---|
| −371.6 | 336.027 | −35.573 | 1.002 | 1.228 × 106 | 8.143 × 10−7 |
The protective effect of HLJDT CFP, HLJDT supernatant, SB-CC CFP and SB-CC supernatant on PC12 cells injured by CoCl2 (data are expressed as means ± SD from three separate experiments).
| Samples | Proliferation Rate (%) | EC50 (µg/mL) | ||||
|---|---|---|---|---|---|---|
| 3.75 µg/mL | 7.5 µg/mL | 15 µg/mL | 30 µg/mL | 60 µg/mL | ||
| 2.36 ± 0.30 | 11.46 ± 3.67 | 46.67 ± 6.06 | 60.28 ± 3.83 | 45.24 ± 5.01 | 28.41 ± 2.61 | |
| 39.49 ± 7.06 | 53.28 ± 5.57 | 56.46 ± 5.69 | 83.18 ± 4.69 | 19.83 ± 4.20 | 14.71 ± 0.91 | |
| 11.43 ± 3.26 | 14.79 ± 4.01 | 14.19 ± 0.69 | 24.16 ± 5.95 | 10.60 ± 2.93 | 56.47 ± 2.63 | |
| 32.58 ± 4.44 | 58.04 ± 5.87 | 66.28 ± 2.19 | 123.91 ± 9.41 | 84.64 ± 4.69 | 6.11 ± 0.12 | |
Figure 5Morphological changes of PC12 cells under a light microscope. (a) Control group; (b) Model group; (c) Pretreatment with 30 μg/mL of HLJDT supernatant then injured by CoCl2; (d) Pretreatment with 30 μg/mL of HLJDT CFP then injured by CoCl2; (e) Pretreatment with 30 μg/mL of SB-CC supernatant then injured by CoCl2 and (f) Pretreatment with 30 μg/mL of SB-CC CFP then injured by CoCl2 (×400).